OpenAI partners with PerturbAI to deploy nearly 2,000 AI agents for collaborative research, accelerating new drug development.
Working with the reasoning framework developed by the research institute, the system completed an analysis task that would take humans months in just 32 minutes. Experts favored the results from multiple agents and plan to collaborate on discovering new drug targets.
Return to original text
A short introduction is retained here; the full text from the source website is not reposted. For specific wording and subsequent updates, please refer to the original article.
Open the original article on ITHome